Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Muscular Dystrophy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07415837
What this trial is testing

Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies

Who this might be right for
Duchenne / Becker Muscular DystrophyDystrophia Myotonica 1Congenital Myopathies+1 more
University Hospital, Clermont-Ferrand 104
Not applicableLooking for participantsNCT06839469
What this trial is testing

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Who this might be right for
Spinal Muscular Atrophy Type 3Duchenne Muscular Dystrophy (DMD)
Columbia University 106
Not applicableStudy completedNCT04349566
What this trial is testing

Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases

Who this might be right for
Becker Muscular DystrophyMcArdle DiseaseLimb-Girdle Muscular Dystrophy Type 2
Mads Peter Godtfeldt Stemmerik 36
Testing effectiveness (Phase 2)Study completedNCT01350154
What this trial is testing

Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients

Who this might be right for
Becker Muscular Dystrophy
Rigshospitalet, Denmark 17
Early research (Phase 1)Study completedNCT02295748
What this trial is testing

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort

Who this might be right for
Duchenne Muscular Dystrophy
PTC Therapeutics 24
Not applicableLooking for participantsNCT07630389
What this trial is testing

Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1Congenital DM1Juvenile DM1+1 more
University of Rochester 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05524883
What this trial is testing

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Dyne Therapeutics 86
Early research (Phase 1)Study completedNCT00428935
What this trial is testing

Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Nationwide Children's Hospital 6
Not applicableLooking for participantsNCT07092540
What this trial is testing

The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
University of Rochester 105
Not applicableUnknownNCT02880735
What this trial is testing

Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy 1Steinert Disease
National Institute of Respiratory Diseases, Mexico 27
Not applicableUnknownNCT05029232
What this trial is testing

Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital

Who this might be right for
Duchenne Muscular Dystrophy
Sohag University 50
Large-scale testing (Phase 3)Ended earlyNCT05689164
What this trial is testing

Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy.

Who this might be right for
Duchenne Muscular Dystrophy
Pfizer 7
Post-approval studies (Phase 4)UnknownNCT00606775
What this trial is testing

The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular DystrophyCardiomyopathies
Suzuka Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT03917719
What this trial is testing

An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Catabasis Pharmaceuticals 130
Large-scale testing (Phase 3)Looking for participantsNCT07038200
What this trial is testing

Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

Who this might be right for
Facioscapulohumeral Muscular DystrophyFSHDFSHD - Facioscapulohumeral Muscular Dystrophy+14 more
Avidity Biosciences, Inc. 200
Not applicableStudy completedNCT05099107
What this trial is testing

Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment

Who this might be right for
Congenital MyopathyNeuromuscular DiseasesMusculoskeletal Diseases+3 more
Vastra Gotaland Region 18
Not applicableLooking for participantsNCT05982119
What this trial is testing

Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study

Who this might be right for
Duchenne Muscular DystrophyFascioscapulohumeral Muscular DystrophyMyotonic Dystrophy 1+3 more
Centre Hospitalier Universitaire de Liege 300
Not applicableUnknownNCT03930628
What this trial is testing

Limb-Girdle Muscular Dystrophy Type 2I in Norway

Who this might be right for
Limb Girdle Muscular Dystrophy, Type 2ILimb Girdle Muscular DystrophyMuscular Dystrophies+1 more
University Hospital of North Norway 106
Early research (Phase 1)WithdrawnNCT02241928
What this trial is testing

Stem Cell Therapy in Muscular Dystrophy

Who this might be right for
Muscular Dystrophy
Neurogen Brain and Spine Institute
Large-scale testing (Phase 3)Looking for participantsNCT06523400
What this trial is testing

The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2

Who this might be right for
Myotonic Dystrophy
Lupin Ltd. 176
Next Page